A detailed history of Lsv Asset Management transactions in Organon & Co. stock. As of the latest transaction made, Lsv Asset Management holds 4,488,828 shares of OGN stock, worth $95.7 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
4,488,828
Previous 3,349,579 34.01%
Holding current value
$95.7 Million
Previous $48.3 Million 74.72%
% of portfolio
0.17%
Previous 0.11%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 06, 2024

BUY
$13.78 - $18.8 $15.7 Million - $21.4 Million
1,139,249 Added 34.01%
4,488,828 $84.4 Million
Q4 2023

Feb 06, 2024

BUY
$10.95 - $17.32 $3.48 Million - $5.5 Million
317,727 Added 10.48%
3,349,579 $48.3 Million
Q3 2023

Nov 03, 2023

BUY
$16.59 - $23.77 $4.17 Million - $5.98 Million
251,400 Added 9.04%
3,031,852 $52.6 Million
Q2 2023

Aug 02, 2023

BUY
$19.27 - $24.63 $1.4 Million - $1.79 Million
72,773 Added 2.69%
2,780,452 $57.9 Million
Q1 2023

May 02, 2023

BUY
$21.42 - $32.08 $3.47 Million - $5.2 Million
161,960 Added 6.36%
2,707,679 $63.7 Million
Q4 2022

Feb 08, 2023

BUY
$23.31 - $28.61 $95,244 - $116,900
4,086 Added 0.16%
2,545,719 $71.1 Million
Q3 2022

Nov 07, 2022

BUY
$23.4 - $34.25 $15.9 Million - $23.3 Million
681,083 Added 36.61%
2,541,633 $59.5 Million
Q2 2022

Aug 10, 2022

BUY
$31.66 - $38.9 $20.8 Million - $25.6 Million
658,351 Added 54.76%
1,860,550 $62.8 Million
Q1 2022

May 12, 2022

BUY
$30.45 - $39.36 $3.36 Million - $4.34 Million
110,214 Added 10.09%
1,202,199 $42 Million
Q4 2021

Jan 28, 2022

BUY
$28.67 - $37.13 $2.79 Million - $3.61 Million
97,270 Added 9.78%
1,091,985 $33.3 Million
Q3 2021

Nov 04, 2021

SELL
$28.63 - $35.64 $1.38 Million - $1.72 Million
-48,202 Reduced 4.62%
994,715 $32.6 Million
Q2 2021

Aug 04, 2021

BUY
$28.45 - $38.0 $29.7 Million - $39.6 Million
1,042,917 New
1,042,917 $31.6 Million

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $5.42B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Lsv Asset Management Portfolio

Follow Lsv Asset Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lsv Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Lsv Asset Management with notifications on news.